Logotype for GE HealthCare Technologies Inc

GE HealthCare Technologies (GEHC) Investor Day 2024 summary

Event summary combining transcript, slides, and related documents.

Logotype for GE HealthCare Technologies Inc

Investor Day 2024 summary

8 Jul, 2026

Strategic Priorities and Growth Framework

  • Targeting mid-single-digit organic revenue growth (4–6% CAGR) through 2028, driven by innovation, margin expansion, and recurring revenue.

  • Four strategic pillars: leadership products, business optimization, precision care, and new revenue models (SaaS, M&A).

  • R&D investment increased from 4% to 6% of sales, with over $2.2B invested since 2022 and a focus on high-impact product launches.

  • Recurring revenue now over 45% of total, with a long-term target of 60% through services, SaaS, and consumables; digital revenue expected to grow 50% to $1.8B by 2028.

  • Margin expansion plan targets high teens to 20%+ EBIT, supported by productivity, platforming, and innovation.

Innovation and Technology Strategy

  • Over 100 new products launched since the spin-off; 25+ imaging NPIs and 40 AVS NPIs planned for the midterm.

  • Leading in AI med tech with 80 FDA-cleared AI-enabled products, aiming for 200+ by 2028.

  • Major launches include photon counting CT (Deep Silicon), next-gen MR, Flyrcado (cardiac PET), Vizamyl (Alzheimer’s PET), and CareIntellect for Oncology.

  • Digital and SaaS backbone to enable new recurring revenue streams, with the first enterprise SaaS product launching in 2025.

  • Strategic M&A and partnerships to broaden capabilities in high-growth adjacencies and digital health.

Segment Highlights and Market Positioning

  • Imaging: $8.9B revenue, 9.2% EBIT margin, 4-5% market CAGR, 300,000+ installed base, focus on AI and molecular imaging.

  • AVS: $5.1B revenue, 800,000 installed base, 40 NPIs planned, integration of ultrasound and interventional labs for margin and growth.

  • PCS: $3.1B revenue, 4M installed base, 10 NPIs planned, targeting 400bps margin improvement via digital and supply chain.

  • PDx: $2.3B revenue, 26.8% margin, high single-digit growth, pipeline of 8 assets, leveraging unique integration with imaging.

  • Strategic partnerships and enterprise deals ($4B+ since spin) drive recurring revenue and customer stickiness.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more